Clinical Trial Update: Modafinil's Effects on Cognition in Remitted MDD [Phase 3]

View source ↗

Summary

Phase 3 trial investigating modafinil for cognitive impairment in remitted major depressive disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Major Depressive Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Unity Health Toronto | Conditions: Major Depressive Disorder, Cognitive Impairment | Phase 3 | Status: TERMINATED